NCT06966596View on ClinicalTrials.gov

Low-Dose Ketamine Infusion for Post-Operative Pain in Patients Undergoing Laparoscopic Cholecyctectomy

PHASE1CompletedINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Laparoscopic Cholecystectomy

Interventions

DRUG

Ketamine only

Group A received ketamineat 0.2mg/kg bolus intravenously followed by ketamine infusion at rate of 0.2mg/kg/hr throughout the surgery. W

OTHER

Placebo Normal Saline (NS)

Control group received normal saline to maintain double blinding

Trial Locations (1)

Unknown

Fazaia Ruth Pfau Medical College, PAF Hospital Base Faisal, Karachi

All Listed Sponsors

lead

Fazaia Ruth Pfau Medical College

OTHER

NCT06966596 - Low-Dose Ketamine Infusion for Post-Operative Pain in Patients Undergoing Laparoscopic Cholecyctectomy | Biotech Hunter | Biotech Hunter